Brain cell swelling during hypocapnia increases with hyperglycemia or ketosis

Nicole Glaser1, Angeliki Bundros, Steve Anderson

  • 1Department of Pediatrics, University of California Davis, School of Medicine, Sacramento, CA, USA.

Pediatric Diabetes
|January 22, 2014
PubMed

Insights

Severe hypocapnia (low carbon dioxide) reduces blood flow to the brain. Hyperglycemia and ketosis worsen brain cell swelling during hypocapnia, increasing vulnerability to injury.

Area of Science:

  • Neuroscience
  • Physiology
  • Medical Research

Background:

  • Severe hypocapnia (low carbon dioxide) reduces cerebral blood flow (CBF), a risk factor for diabetic ketoacidosis (DKA)-related cerebral edema and injury in children.
  • Hypocapnia-induced CBF reduction alone is unlikely to cause significant cerebral injury.
  • Investigated if hyperglycemia or ketosis alters hypocapnia's effects on CBF and cerebral edema.

Purpose of the Study:

  • To determine how hyperglycemia and ketosis affect cerebral blood flow (CBF) and brain cell swelling during hypocapnia.
  • To assess the role of metabolic states in hypocapnia-induced cerebral alterations.
  • To understand the mechanisms of brain injury in diabetic ketoacidosis.

Main Methods:

  • Juvenile rats were subjected to hypocapnia (low pCO₂) via mechanical ventilation.
  • Groups included controls, hyperglycemic rats, and ketotic rats.
  • Magnetic resonance imaging (MRI) measured CBF and apparent diffusion coefficient (ADC) to assess brain cell swelling.

Main Results:

  • Hypocapnia reduced CBF in all rat groups.
  • Hyperglycemia and ketosis did not significantly alter hypocapnia's effect on CBF.
  • Brain cell swelling (decreased ADC) during hypocapnia was significantly greater in hyperglycemic and ketotic rats.

Conclusions:

  • Brain cell swelling during hypocapnia is exacerbated by hyperglycemia and ketosis.
  • These metabolic conditions increase brain vulnerability to injury during hypocapnia.
  • Findings suggest a mechanism for increased brain injury risk in DKA.
Abstract

Related Concept Videos

Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
30
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
20
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous...
20
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic...
30
Hyperpnea and Hyperventilation01:25

Hyperpnea and Hyperventilation

Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
4.1K
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25